Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Februar 2019

Planlagt Fastgjort Låst Flyttet Genmab
3.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • R Offline
    R Offline
    Raketten50
    wrote on sidst redigeret af
    #1076

    Og flere detaljer her: https://www.mhlw.go.jp/content/11123000/000451939.pdf

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #1077

      Kunne se ud til at sakigake er på 6 mdr.men vi ved ikke om Janssen har fået det.

      1 Reply Last reply
      0
      • S Offline
        S Offline
        Sukkeralf
        wrote on sidst redigeret af
        #1078

        Just a moment...

        favicon

        (www.firstwordpharma.com)

        1 Reply Last reply
        0
        • SolsenS Offline
          SolsenS Offline
          Solsen
          wrote on sidst redigeret af
          #1079

          Hold da op. Så forstår jeg da ingenting af den handel BMY har gang i. Godt for Daras salg mener jeg tillige.

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #1080

            Jeg troede ikke at det var allerede nu

            1 Reply Last reply
            0
            • Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktør
              wrote on sidst redigeret af
              #1081

              Enig Solsen.

              1 Reply Last reply
              0
              • SolsenS Offline
                SolsenS Offline
                Solsen
                wrote on sidst redigeret af
                #1082

                Jeg har gravet meget i det. Men kom frem til 2022 på grundlag af mange artikler.

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #1083

                  Så får de nok en patentsag på halsen 😉

                  1 Reply Last reply
                  0
                  • H Offline
                    H Offline
                    Hamming
                    wrote on sidst redigeret af
                    #1084

                    Just a moment...

                    favicon

                    (journals.lww.com)

                    1 Reply Last reply
                    0
                    • H Offline
                      H Offline
                      Hamming
                      wrote on sidst redigeret af
                      #1085

                      Godt overblik

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #1086

                        Suverænt link. Tak Hamming.

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          peter12
                          wrote on sidst redigeret af
                          #1087

                          Mere om Revlimid http://www.gabionline.net/Generics/News/Alvogen-receives-European-approval-for-generic-lenalidomide

                          1 Reply Last reply
                          0
                          • BulderB Offline
                            BulderB Offline
                            Bulder
                            wrote on sidst redigeret af
                            #1088

                            Flere af disse patenter ser ud til at udløbe i 2020 https://www.drugs.com/availability/generic-revlimid.html

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #1089

                              Mystisk: The patents on Revlimid’s ‘last-to-expire’ key patents, according to C
                              elgene, are only due to expire in the US in 2027 and in Europe in 2024.

                              1 Reply Last reply
                              0
                              • SolsenS Offline
                                SolsenS Offline
                                Solsen
                                wrote on sidst redigeret af
                                #1090

                                Der kan være meget forskel på lande og verdensdele. Men det bliver et hullet tæppe som tiden går. Så vi ikke forleden "Doctor Reddys" der opgav - sikkert imod betaling fra CELG (Husker ikke navnet)

                                1 Reply Last reply
                                0
                                • SolsenS Offline
                                  SolsenS Offline
                                  Solsen
                                  wrote on sidst redigeret af
                                  #1091

                                  CELG har gjort alt for at forlænge patentet og tillige købt konkurrenter til at opgive eller udsætte launch.

                                  1 Reply Last reply
                                  0
                                  • BulderB Offline
                                    BulderB Offline
                                    Bulder
                                    wrote on sidst redigeret af
                                    #1092

                                    Så nu bliver de nødt til at købe Genmab? 😉

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #1093

                                      Mike Thompson in good Dara mood today https://twitter.com/mtmdphd/status/1095658187859132416 https://twitter.com/mtmdphd/status/1095658194779676672

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        peter12
                                        wrote on sidst redigeret af
                                        #1094

                                        Endnu mere om Revlimid http://www.taipeitimes.com/News/biz/archives/2017/09/09/2003678067

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          peter12
                                          wrote on sidst redigeret af
                                          #1095

                                          Upon the expiration or loss of patent protection for a product, or upon the “at-risk” launch by a manufacturer of a generic version of one of our products, we can quickly lose a significant portion of our sales of that product. In addition, as additional competitors enter the market, our patented products may face increased competition or pricing pressure http://q4live.s22.clientfiles.s3-website-us-east-1.amazonaws.com/728481125/files/doc_financials/2018/b0b91209-0f73-447c-93ab-9027fb4c6bbf.pdf

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger